Global Survey Reveals Urgency to Accelerate Study Start-up

Author's Avatar
Jul 23, 2020
Article's Main Image

Accelerating study start-up is a top priority for life sciences companies according to the Veeva+2020+Study+Start-up+Pulse+Report+%26amp%3B+Assessing+Post-COVID+Readiness, a global study start-up survey of more than 500 clinical operations professionals. Findings from Veeva+Systems (NYSE: VEEV) show an industrywide shift to streamline study activation and speed clinical trials.